Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes.

Source:http://linkedlifedata.com/resource/pubmed/id/17261957

Download in:

View as

General Info

PMID
17261957